Cannabis Confidential

Cannabis Confidential

Share this post

Cannabis Confidential
Cannabis Confidential
Grow Up

Grow Up

New states position for 2025.

Todd Harrison's avatar
Todd Harrison
Dec 17, 2024
∙ Paid
2

Share this post

Cannabis Confidential
Cannabis Confidential
Grow Up
Share

Daily Recap

Pennsylvania lawmakers are feeling optimistic about their chances of legalizing adult-use marijuana in the 2025 session, and the governor plans to once again call for the reform as part of his next budget proposal.

Gov. Josh Shapiro (D) said that he will put adult-use canna legalization in his budget request—as he did his last two budgets—and lawmakers and advocates are confident the third time may be the charm.

Cheese Please

The minority leader of Wisconsin’s Senate said this week that she plans to introduce a medical marijuana legalization bill in the coming legislative session, building on past efforts that have fallen short in the face of pushback from Republican lawmakers.

Sen. Dianne Hesselbein (D) believes the measure has a realistic chance at passage in given recent Democratic pickups in the Senate ended the GOP’s supermajority control of the chamber.

“With 18 Republicans and 15 Democrats, I think they’re going to need our votes to get anything done in the state Senate.”

Mace is the Place

A Republican senator in South Carolina prefiled a bill for the 2025 session that would legalize medical marijuana in the state. The legislation, from Sen. Tom Davis (R), brings back a proposal that passed the Senate last session but wasn’t taken up in the House.

Davis told reporters that cannabis “can be a therapeutic benefit in many respects, and a lot less intrusive way than opioids or the pharmaceuticals.”

Three Letter Agency

The DEA made a major blunder in its subpoena request for witnesses in the upcoming cannabis rescheduling hearing. Still, an administrative law judge appears to be giving the agency another shot.

DEA Chief ALJ John J. Mulrooney issued an order granting the DEA just one of its four subpoena requests made Dec. 13 for FDA officials to appear as witnesses for the hearing’s testimonials that are scheduled to run from Jan. 21 through March 6.

Stocks & Stuff

After setting a new all-time low yesterday, U.S. cannabis ETF MSOS bounced 7% today on a combination of factors—and perhaps a whiff of hopium. Some of the individual names traded better, let by TerrAscend, which rallied 24% on the session.

Below, we’ll top-line the landscape, talk some truth about the current state of affairs, offer perspective on tax liabilities, flag a few outliers and otherwise try to keep it real.

All that and more, just scroll down.

I’ll be offline Dec. 20th through New Year’s. Healthy & safe holidays to you and yours.

SPY 0.00%↑ QQQ 0.00%↑ IWM 0.00%↑ MSOS 0.00%↑ ETF Notional: $54M

Top Stories

Keep reading with a 7-day free trial

Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Todd Harrison
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share